[Method for evaluation of the effect of teratogenic agents (6-azauridine) on late development stages].
D000014:Abnormalities, Drug-Induced; D000818:Animals; D000963:Antimetabolites / Q000009:adverse effects*; D001380:Azauridine / Q000009:adverse effects; D002642:Chick Embryo; D005314:Embryonic and Fetal Development; D005260:Female; D005333:Fetus / Q000187:drug effects*; D005865:Gestational Age; D008431:Maternal-Fetal Exchange / Q000187:drug effects; D011247:Pregnancy; D013997:Time Factors; D014529:Uridine / Q000009:adverse effects*
D000963:Antimetabolites; D001380:Azauridine; D014529:Uridine
O zuůsobu hodnocení úcinku teratogenních agens (6-azauridinu) na pozdních vývojových stadiích.